Five million bird flu vaccines for UK plan

Vacines are being made for bird blue - Getty
Vacines are being made for bird blue - Getty
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The Herald.

The UK government has confirmed it has stockpiled five million vaccine doses as a contingency for an avian influenza outbreak this winter.

The vaccines would be deployed if the H5N1 strain begins spreading among humans, forming part of the UK’s preparations for a potential influenza pandemic.

The influenza A(H5N1) virus has been responsible for a prolonged global outbreak in recent years, largely affecting poultry and wild birds.

This season, three cases of avian influenza have been confirmed in kept poultry, involving a mix of the H5N5 and H5N1 strains. However, the UK Health Security Agency (UKHSA) has stated: "There is no evidence of human-to-human transmission."

A UK-based healthcare company, CSL Seqirus UK Ltd, will manufacture the vaccine, which is designed based on a current H5 avian influenza virus.

Dr Meera Chand from the UKHSA said: "It is important for us to be prepared against a range of different influenza viruses that may pose human health risks.

"Early access to vaccines saves lives. Adding H5 vaccines to the interventions already available to us will help us to be ready for a wider range of threats.

"It is only if this virus were to start spreading among humans, of which there is no evidence at this stage, that the human H5 influenza vaccine would be used."

The Animal and Plant Health Agency (APHA) emphasised the importance of its work in monitoring and responding to avian influenza. It said: "This work is of vital importance in preparing and responding to emerging pathogen threats to the UK, helping us to contribute to a better understanding of the disease and offering reassurance to the public."

Get involved
with the news

Send your news & photos